MedTrace Logo

Lipid Profile and Diabetes Mellitus in People With HIV

NCT04125784 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 450

Last updated 2023-03-31

No results posted yet for this study

Summary

Traditional risk factors for cardiovascular diseases have been shown to have an even higher impact in the HIV infected population. The original study from 2014 was a cross sectional study into the prevalence of cardiovascular risk factors (namely, dyslipidaemia and diabetes mellitus) in people living with HIV (PLWHIV) in Austria. The aim of this follow up study is to see the progression of our study sample and to see what prevalence levels may be found after 7 years. This epidemiological evaluation is conceptualized to document real life major cardiovascular risk factors of HIV-infected patients, focusing on lipid profiles and diabetes mellitus risk and to compare with the baseline values from the original study.

Conditions

Sponsors & Collaborators

  • Merck Gesellschaft mbH, Austria

    collaborator INDUSTRY

  • Moritz Oberndorfer

    lead OTHER

Principal Investigators

  • Thomas E Dorner, MD, MPH · Medical University of Vienna

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-01
Primary Completion
2022-12-30
Completion
2023-02-28

Countries

  • Austria

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04125784 on ClinicalTrials.gov